- Home
- MLYS vs KMPR Comparison
MLYS vs KMPR Comparison
Compare MLYS & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLYS | KMPR |
|---|---|---|
| Founded | 2019 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLYS | KMPR |
|---|---|---|
| Price | $31.07 | $32.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $47.33 | ★ $47.50 |
| AVG Volume (30 Days) | ★ 1.2M | 943.4K |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.29 |
| Revenue | N/A | ★ $4,789,700,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.55 |
| P/E Ratio | ★ N/A | $14.89 |
| Revenue Growth | N/A | ★ 3.24 |
| 52 Week Low | $8.24 | $30.05 |
| 52 Week High | $47.65 | $69.83 |
Technical Indicators
Market Signals| Indicator | MLYS | KMPR |
|---|---|---|
| Relative Strength Index (RSI) | 44.90 | 21.33 |
| Support Level | $28.17 | $30.05 |
| Resistance Level | $31.83 | $39.67 |
| Average True Range (ATR) | 1.67 | 1.28 |
| MACD | 0.11 | -0.60 |
| Stochastic Oscillator | 48.77 | 24.23 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.